Eczemas may be characterized by which of the following?

• A. Heterogeneous clinical symptoms.
• B. Type 1 hypersensitivity reaction in the pathogenesis.
• C. Topical corticosteroid use in the most severe cases only.
• D. An exclusive appearance in childhood and elderly populations only.

Answer: (A)

Eczema is a spectrum of inflammatory skin diseases with a wide range of presentations and triggers. Because different subtypes (such as atopic dermatitis, allergic contact dermatitis, irritant dermatitis, etc.) can look very different and arise from distinct mechanisms, the overall picture is one of heterogeneous clinical symptoms. Some forms involve Th2-skewed immune responses and barrier defects with IgE sensitization, while others are driven by delayed-type (Type IV) hypersensitivity or purely irritant injury. This variety is why the best description is that eczemas have heterogeneous clinical features.

Topical corticosteroids are a common treatment across many severities of active inflammation, not only in the most severe cases. Eczema can occur across ages, not exclusively in childhood and the elderly, and management is tailored to the specific subtype and severity, not limited to one age group. And while some eczemas involve IgE-mediated processes, others are driven by non–IgE mechanisms, so describing the pathogenesis as a single Type I hypersensitivity pathway would be inaccurate.